Earnings Release: Here's Why Analysts Cut Their OptimizeRx Corporation (NASDAQ:OPRX) Price Target To US$15.79 [Yahoo! Finance]
OptimizeRx Corporation (OPRX)
NASDAQ:AMEX Investor Relations:
optimizerx.com/investors
Company Research
Source: Yahoo! Finance
Revenues of US$19m came in a modest 8.1% below forecasts. Statutory losses were a relative bright spot though, with a per-share loss of US$0.22 coming in a substantial 34% smaller than what the analysts had expected. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year. See our latest analysis for OptimizeRx Taking into account the latest results, the current consensus from OptimizeRx's seven analysts is for revenues of US$100.9m in 2024. This would reflect a sizeable 21% increase on its revenue over the past 12 months. The loss per share is expected to greatly reduce in the near future, narrowing 33% to US$0.66. Before this earnings announcement, the analysts had been modelling revenues of US$101.0m an
Show less
Read more
Impact Snapshot
Event Time:
OPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPRX alerts
High impacting OptimizeRx Corporation news events
Weekly update
A roundup of the hottest topics
OPRX
News
- OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total ValueGlobeNewswire
- OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare AudiencesGlobeNewswire
- OptimizeRx Co. (NASDAQ: OPRX) had its price target lowered by analysts at Royal Bank of Canada from $17.00 to $14.00. They now have an "outperform" rating on the stock.MarketBeat
- OptimizeRx Co. (NASDAQ: OPRX) had its price target lowered by analysts at Barclays PLC from $15.00 to $11.00. They now have an "equal weight" rating on the stock.MarketBeat
- OptimizeRx Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]Yahoo! Finance
OPRX
Earnings
- 8/8/24 - Beat
OPRX
Sec Filings
- 8/15/24 - Form 10-Q
- 8/15/24 - Form NT
- 8/8/24 - Form 8-K
- OPRX's page on the SEC website